Literature DB >> 25853998

Chlamydia psittaci: update on an underestimated zoonotic agent.

Michael R Knittler1, Konrad Sachse2.   

Abstract

Chlamydia (C.) psittaci is an economically relevant pathogen in poultry and pet birds, where it causes psittacosis/ornithosis, and also a human pathogen causing atypical pneumonia after zoonotic transmission. Despite its well-documented prevalence, the agent has received less attention by researchers than other Chlamydia spp. in the last decades. In the present paper, we review recently published data on C. psittaci infection and attempt to single out characteristic features distinguishing it from related chlamydial agents. It is remarkable that C. psittaci is particularly efficient in disseminating in the host organism causing systemic disease, which occasionally can take a fulminant course. At the cellular level, the pathogen's broad host cell spectrum (from epithelial cells to macrophages), its rapid entry and fast replication, proficient use of intracellular transport routes to mitochondria and the Golgi apparatus, the pronounced physical association of chlamydial inclusions with energy-providing cell compartments, as well as the subversive regulation of host cell survival during productive and persistent states facilitate the characteristic efficient growth and successful host-to-host spread of C. psittaci. At the molecular level, the pathogen was shown to upregulate essential chlamydial genes when facing the host immune response. We hypothesize that this capacity, in concert with expression of specific effectors of the type III secretion system and efficient suppression of selected host defense signals, contributes to successful establishment of the infection in the host. Concerning the immunology of host-pathogen interactions, C. psittaci has been shown to distinguish itself by coping more efficiently than other chlamydiae with pro-inflammatory mediators during early host response, which can, to some extent, explain the effective evasion and adaptation strategies of this bacterium. We conclude that thorough analysis of the large number of whole-genome sequences already available will be essential to identify genetic markers of the species-specific features and trigger more in-depth studies in cellular and animal models to address such vital topics as treatment and vaccination. © FEMS 2014. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Chlamydia psittaci; animal models; epidemiology; host adaptation; immune evasion; immune response; molecular and clinical pathogenesis; whole-genome analysis

Mesh:

Substances:

Year:  2014        PMID: 25853998     DOI: 10.1093/femspd/ftu007

Source DB:  PubMed          Journal:  Pathog Dis        ISSN: 2049-632X            Impact factor:   3.166


  56 in total

1.  Immunization with Chlamydia psittaci plasmid-encoded protein CPSIT_p7 induces partial protective immunity against chlamydia lung infection in mice.

Authors:  Yuan Tan; Yumeng Li; Yang Zhang; Jian Yu; Yating Wen; Chuan Wang; Man Xu; Qian Chen; Chunxue Lu; Yimou Wu
Journal:  Immunol Res       Date:  2018-08       Impact factor: 2.829

Review 2.  Community-acquired pneumonia related to intracellular pathogens.

Authors:  Catia Cillóniz; Antoni Torres; Michael Niederman; Menno van der Eerden; James Chalmers; Tobias Welte; Francesco Blasi
Journal:  Intensive Care Med       Date:  2016-06-08       Impact factor: 17.440

3.  Chlamydia Lipooligosaccharide Has Varied Direct and Indirect Roles in Evading both Innate and Adaptive Host Immune Responses.

Authors:  Xisheng Wang; Daniel D Rockey; Brian P Dolan
Journal:  Infect Immun       Date:  2020-07-21       Impact factor: 3.441

Review 4.  Redox Homeostasis in Poultry: Regulatory Roles of NF-κB.

Authors:  Peter F Surai; Ivan I Kochish; Michael T Kidd
Journal:  Antioxidants (Basel)       Date:  2021-01-28

5.  Simultaneous Intramuscular And Intranasal Administration Of Chitosan Nanoparticles-Adjuvanted Chlamydia Vaccine Elicits Elevated Protective Responses In The Lung.

Authors:  Yumeng Li; Chuan Wang; Zhenjie Sun; Jian Xiao; Xiaoliang Yan; Yuqing Chen; Jian Yu; Yimou Wu
Journal:  Int J Nanomedicine       Date:  2019-10-08

6.  Epidemiology of Marginal Zone Lymphoma.

Authors:  James R Cerhan; Thomas M Habermann
Journal:  Ann Lymphoma       Date:  2021-03-30

7.  The growing repertoire of genetic tools for dissecting chlamydial pathogenesis.

Authors:  Arkaprabha Banerjee; David E Nelson
Journal:  Pathog Dis       Date:  2021-05-11       Impact factor: 3.166

8.  Intranasal immunization with inactivated chlamydial elementary bodies formulated in VCG-chitosan nanoparticles induces robust immunity against intranasal Chlamydia psittaci challenge.

Authors:  Zonghui Zuo; Yongjuan Zou; Qiang Li; Yongxia Guo; Tianyuan Zhang; Jie Wu; Cheng He; Francis O Eko
Journal:  Sci Rep       Date:  2021-05-17       Impact factor: 4.379

9.  A 25-year retrospective study of Chlamydia psittaci in association with equine reproductive loss in Australia.

Authors:  Rumana Akter; Fiona M Sansom; Charles M El-Hage; James R Gilkerson; Alistair R Legione; Joanne M Devlin
Journal:  J Med Microbiol       Date:  2021-02       Impact factor: 2.472

Review 10.  On the offense and defense: mitochondrial recovery programs amidst targeted pathogenic assault.

Authors:  Siraje A Mahmud; Mohammed A Qureshi; Mark W Pellegrino
Journal:  FEBS J       Date:  2021-07-16       Impact factor: 5.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.